Juan Viloca (player) was reported for a violation of the Anti-Doping Rules, during the ATP Sanctioned challenger tournament at the Bonasport Club of Barcelona, Spain on October 9 2004. The provided urine sample tested positive 16a-hydroxprednisolone (budesonide metabolite) a S 9 glucocorticosteroids which is a prohibited substance according the Anti-Doping Rules.
The player was notified and he didn't ask for a B-sample analysis, which automatically means he committed a doping offense. For this reason a hearing before the full tribunal was no longer needed. The cause of the positive test is the use of a nasal inhalator with "nasal budesonide" for his condition of extrinsic continuous rhinitis, for which he didn't apply for a therapeutic use exemption (Tue). The tribunal agrees that the prohibited substance wasn't used for enhancing sport performance.
Decision
1. The Player admitted a First Doping Offense thereby establishing that a Doping Offense has occurred as defined in Rule C 1. The Doping Offense involved the use of a Specified Substance, a Glucocorticosteroid referred to in S. 9. of Appendix Three “The 2004 Prohibited List” as a specified substance.
2. Rule L. 1. disqualifies the results obtained at the “ATP Challenger Tournament” in Barcelona, Spain on 9 October 2004. Any medals, titles, computer ranking points and prize money (without reduction for tax) obtained at the competition are forfeited. The commencement of the foregoing consequences is to be effective in accordance with Rule M. 8.
3. Under Rule M. 3. the period of ineligibility otherwise applicable is determined to be the period of voluntarily foregoing participation in Competitions. In accordance with Rule M. 8. c. this (1 year) Ineligibility shall terminate on the day following April 15, 2005.
